April 15, 2024



Vir Biotechnology Inc., a publicly traded firm seeking to develop treatments for infectious diseases, is closing its Portland location as part of a wider cost-cutting initiative.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *